KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioMarket CapitalizationNet MarginOperating MarginReturn on SalesTimes Interest Earned

Palvella Therapeutics (PVLA) Gross Margin: 2014-2024

Historic Gross Margin for Palvella Therapeutics (PVLA) over the last 11 years, with Dec 2024 value amounting to 100.00%.

  • Palvella Therapeutics' Gross Margin changed negligibly% to 100.00% in Q4 2024 from the same period last year, while for Dec 2024 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • Palvella Therapeutics' Gross Margin amounted to 100.00% in Q4 2024, which was down 0.00% from 100.00% recorded in Q3 2024.
  • Palvella Therapeutics' Gross Margin's 5-year high stood at 100.00% during Q1 2020, with a 5-year trough of 100.00% in Q1 2020.
  • Moreover, its 3-year median value for Gross Margin was 100.00% (2024), whereas its average is 100.00%.